Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
4-Substituted anilides as selective melatonin MT2 receptor agonistsJames R Epperson, Jeffrey A Deskus, Anthony J Gentile, et al.Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonistsLi-Qiang Sun, Jie Chen, Marc Bruce, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Diaminopyrimidine and diaminopyridine 5-HT7 ligandsDerek J Denhart, Ashok V Purandare, John D Catt, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Heterocyclic aminopyrrolidine derivatives as melatoninergic agentsLi-Qiang Sun, Jie Chen, Ronald J Mattson, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2013
Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitorsJonathan L Ditta, Derek J Denhart, Jeffrey A Deskus, et al.Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitorsDerek J Denhart, Jeffrey A Deskus, Jonathan L Ditta, et al.Journal of Medicinal Chemistry|October 19, 2010
Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitorsH Dalton King, Zhaoxing Meng, Jeffrey A Deskus, et al.Nuclear Medicine and Biology|May 6, 2014
Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptorsNicholas J Lodge, Yu-Wen Li, Frederick T Chin, et al.Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitorsJeffrey A Deskus, James R Epperson, Charles P Sloan, et al.Bioorganic & Medicinal Chemistry|September 11, 2004
Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amidesJames R Epperson, Marc A Bruce, John D Catt, et al.Pageof 2